National trial safely scales back prescribing of a powerful antipsychotic for the elderly

National trial safely scales back prescribing of a powerful antipsychotic for the elderly

Warning letters from Medicare can safely cut prescribing of a powerful but risky antipsychotic, according to a new study at Columbia University Mailman School of Public Health. Researchers used Medicare data to study the effects of the letters on hundreds of thousands of older adults with dementia.

​Medical Xpress – latest medical and health news stories

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *